This article has been updated from a previous version, which had the incorrect percentage increase in the first paragraph.
For the quarter ended March 31, Sequenom's revenues increased to $6.9 million from $4.3 million in the first quarter of 2005.
The company's net loss for the first quarter was $3.7 million, or $.09 per share, compared to $7.4 million, or $.19 per share for the first quarter of 2005.
Sequenom cut its R&D spending to $2.5 million from $3.3 million in the first quarter of 2005.
On March 31, the company had available cash and short-term investments of $2.9 million.